Market Closed -
Nasdaq
04:00:00 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
10.95
USD
|
-4.62%
|
|
-2.67%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,876
|
-
|
-
|
Enterprise Value (EV)
1 |
4,261
|
4,077
|
3,847
|
P/E ratio
|
15.8
x
|
10.6
x
|
8.79
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.18
x
|
0.16
x
|
0.15
x
|
EV / Revenue
|
0.4
x
|
0.36
x
|
0.31
x
|
EV / EBITDA
|
7.55
x
|
6.62
x
|
5.75
x
|
EV / FCF
|
21.5
x
|
17.5
x
|
-
|
FCF Yield
|
4.64%
|
5.73%
|
-
|
Price to Book
|
1.2
x
|
1.07
x
|
0.93
x
|
Nbr of stocks (in thousands)
|
171,320
|
-
|
-
|
Reference price
2 |
10.95
|
10.95
|
10.95
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
8,826
|
10,607
|
11,422
|
12,472
|
EBITDA
1 |
-
|
537.8
|
564.6
|
615.7
|
668.6
|
EBIT
1 |
-
|
335.5
|
355.5
|
377
|
426.1
|
Operating Margin
|
-
|
3.8%
|
3.35%
|
3.3%
|
3.42%
|
Earnings before Tax (EBT)
1 |
-
|
-177.4
|
71.73
|
210.3
|
265.8
|
Net income
1 |
-53.91
|
-154.6
|
118.2
|
205.4
|
283.7
|
Net margin
|
-
|
-1.75%
|
1.11%
|
1.8%
|
2.27%
|
EPS
2 |
-7.180
|
-1.310
|
0.6929
|
1.034
|
1.246
|
Free Cash Flow
1 |
-
|
137.3
|
197.9
|
233.6
|
-
|
FCF margin
|
-
|
1.56%
|
1.87%
|
2.05%
|
-
|
FCF Conversion (EBITDA)
|
-
|
25.52%
|
35.05%
|
37.95%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
167.4%
|
113.75%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/28/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,375
|
2,577
|
2,619
|
2,656
|
2,754
|
2,784
|
2,834
|
EBITDA
1 |
142.6
|
130.5
|
140.6
|
141.1
|
151.8
|
143
|
157.2
|
EBIT
1 |
91.59
|
81.58
|
84.77
|
88.49
|
95.75
|
87.72
|
89.57
|
Operating Margin
|
3.86%
|
3.17%
|
3.24%
|
3.33%
|
3.48%
|
3.15%
|
3.16%
|
Earnings before Tax (EBT)
|
-14.79
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-6.537
|
-45.75
|
41.05
|
40.92
|
49.07
|
51.68
|
68.27
|
Net margin
|
-0.28%
|
-1.78%
|
1.57%
|
1.54%
|
1.78%
|
1.86%
|
2.41%
|
EPS
2 |
-0.0600
|
-0.2600
|
0.2132
|
0.2256
|
0.2662
|
0.2636
|
0.3282
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/29/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
3,385
|
2,385
|
2,201
|
1,971
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
6.294
x
|
4.223
x
|
3.575
x
|
2.948
x
|
Free Cash Flow
1 |
-
|
137
|
198
|
234
|
-
|
ROE (net income / shareholders' equity)
|
-
|
1.77%
|
9.72%
|
9.01%
|
9.71%
|
ROA (Net income/ Total Assets)
|
-
|
0.22%
|
5.72%
|
6.4%
|
6.57%
|
Assets
1 |
-
|
-71,609
|
2,065
|
3,211
|
4,318
|
Book Value Per Share
2 |
-
|
4.960
|
9.090
|
10.20
|
11.70
|
Cash Flow per Share
2 |
-
|
1.790
|
0.4000
|
1.740
|
2.210
|
Capex
1 |
-
|
73.5
|
78
|
91.8
|
94.5
|
Capex / Sales
|
-
|
0.83%
|
0.74%
|
0.8%
|
0.76%
|
Announcement Date
|
8/28/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
10.95
USD Average target price
16.05
USD Spread / Average Target +46.53% Consensus |
1st Jan change
|
Capi.
|
---|
| 0.00% | 1.88B | | -3.48% | 3B | | +63.29% | 683M | | -11.21% | 461M | | -44.36% | 316M | | -11.01% | 196M | | -15.75% | 132M | | +1.92% | 67.85M |
Home Healthcare Services
|